Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 May 20;40(15):1705-1706.
doi: 10.1200/JCO.22.00177. Epub 2022 Mar 11.

Reply to M. Shibusawa et al

Stefano Luminari  1 , Luca Arcaini  1 , Massimo Federico  1
Affiliations
Comment

Reply to M. Shibusawa et al

Stefano Luminari et al. J Clin Oncol. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Stefano LuminariConsulting or Advisory Role: Roche, Gilead Sciences, Celgene, Genmab, Regeneron, IncyteTravel, Accommodations, Expenses: Janssen, Celgene Luca ArcainiConsulting or Advisory Role: Roche, Janssen-Cilag, Verastem, Incyte, EUSA Pharma, Celgene/Bristol Myers Squibb, Gilead Sciences/kite, ADC TherapeuticsSpeakers' Bureau: EUSA Pharma, NovartisResearch Funding: Gilead SciencesTravel, Accommodations, Expenses: Roche, Celgene, Janssen-Cilag, EUSA Pharma Massimo FedericoConsulting or Advisory Role: Takeda, Menarini, ERYTECH Pharma, MedivationResearch Funding: Takeda (Inst)Travel, Accommodations, Expenses: Takeda Pharmaceutical Taiwan, LtdNo other potential conflicts of interest were reported.

Comment on

  • Response-Adapted Postinduction Strategy in Patients With Advanced-Stage Follicular Lymphoma: The FOLL12 Study.
    Luminari S, Manni M, Galimberti S, Versari A, Tucci A, Boccomini C, Farina L, Olivieri J, Marcheselli L, Guerra L, Ferrero S, Arcaini L, Cavallo F, Kovalchuk S, Skrypets T, Del Giudice I, Chauvie S, Patti C, Stelitano C, Ricci F, Pinto A, Margiotta Casaluci G, Zilioli VR, Merli A, Ladetto M, Bolis S, Pavone V, Chiarenza A, Arcari A, Anastasia A, Dondi A, Mannina D, Federico M; Fondazione Italiana Linfomi. Luminari S, et al. J Clin Oncol. 2022 Mar 1;40(7):729-739. doi: 10.1200/JCO.21.01234. Epub 2021 Oct 28. J Clin Oncol. 2022. PMID: 34709880 Clinical Trial.
  • Response-Adapted Postinduction Strategy in Follicular Lymphoma.
    Shibusawa M, Kusumi E, Murakami J, Tanimoto T. Shibusawa M, et al. J Clin Oncol. 2022 May 20;40(15):1705. doi: 10.1200/JCO.21.02818. Epub 2022 Mar 11. J Clin Oncol. 2022. PMID: 35275704 No abstract available.

LinkOut - more resources